Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole in Children and Adolescents With Tourette's Disorder
NCT01727700Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Nov 2012
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of aripiprazole in Tourette syndrome (TS), sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Nov 2012; status: completed.
02
Drugs
aripiprazole
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on NCT01727700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01727700.